ArticleCancer chemotherapy and pharmacology2011
Imatinib mesylate enhances the malignant behavior of human breast carcinoma cells.
Germana Rappa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papertrialcites it